Autoimmune endocrinopathies are characterised by an increased number of peripheral blood lymphocytes (PBL) expressing activation/ memory markers on their surface. The aim of this study was to determine whether a similar finding could be detected in a group of 11 paediatric and young adult patients suffering from autoimmune polyglandular syndrome type 1 (APS1), also called autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED), as very few data have previously been reported in this field. The control group was made up of 11 sex- and age-matched healthy subjects. Fifteen lymphocyte subsets were compared, in terms of percentage and absolute number, and statistical analysis was performed by the Mann-Whitney test. Measurement of T (CD3+), B (CD19+), natural killer (NK, CD3-CD16/56+), CD4+ and CD8+ T lymphocytes showed that patients with APS1 had a higher percentage and absolute count of T lymphocytes: this was entirely due to the statistically larger CD3+CD4+ fraction. Patients with APS1 also had slightly fewer B and NK lymphocytes, but the difference was negligible. Comparison of CD4+ subpopulations bearing activation and naive/memory antigens (marked by CD69, CD25, anti-HLA-DR, CD45RA and CD45RO) showed that patients with APS1 had generally larger percentages and absolute counts of these subsets: however, only the percentage and absolute size of the CD4+CD25+ subset (p = 0.0354 and p = 0.0151, respectively), and the absolute number of the CD4+ anti-HLA-DR+ and CD4+ CD45RO+ subsets (p = 0.0193 and p = 0.0209, respectively) were significantly higher. Interestingly, patients with APS1 also had significantly fewer CD8+CD11b+ and CD3-CD8+ cells. In conclusion, PBL distribution in APS1 resembles that of other autoimmune diseases. Further studies are needed to confirm and possibly extend these data.

Download full-text PDF

Source
http://dx.doi.org/10.1515/jpem.2005.18.2.155DOI Listing

Publication Analysis

Top Keywords

patients aps1
16
percentage absolute
12
peripheral blood
8
blood lymphocytes
8
autoimmune polyglandular
8
polyglandular syndrome
8
syndrome type
8
absolute number
8
aps1 fewer
8
aps1
6

Similar Publications

Article Synopsis
  • * Genetic analysis using trio-based exome sequencing found benign variants of the AIRE gene in all participants, which helped differentiate AAI and exclude APS type 1.
  • * The study recommends whole genome analysis in future research to discover genetic predictors of autoimmune diseases, after identifying risk alleles in patients and noting the prevalence of specific haplotypes in healthy individuals.
View Article and Find Full Text PDF
Article Synopsis
  • This case report highlights dilated cardiomyopathy as a serious heart complication in autoimmune polyendocrine syndrome type 1 (APS-1), stressing the importance of early detection and teamwork among healthcare providers.
  • APS-1, a rare genetic disorder caused by mutations in the AIRE gene, typically presents with symptoms like mucocutaneous candidiasis, adrenal insufficiency, and hypoparathyroidism.
  • The reported case involves a 28-year-old male with multiple symptoms confirming APS-1, indicating the necessity for comprehensive care and regular follow-up to enhance patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Autoimmune polyglandular syndrome 1 (APS1) is a genetic disorder characterized by multiple autoimmune issues, including candidiasis, hypoparathyroidism, and adrenal insufficiency, caused by mutations in the autoimmune regulator gene.
  • A case study of a 39-year-old woman with APS1 highlighted her severe health challenges, including childhood fungal infections that led to a bone marrow transplant and adult-onset partial lipodystrophy marked by significant fat loss.
  • Research showed pathogenic variants in her genetic profile and the presence of specific autoantibodies, suggesting potential links to fat tissue issues, though the exact cause of her lipodystrophy remains unclear.
View Article and Find Full Text PDF
Article Synopsis
  • Autoimmune polyendocrine syndrome type 1 (APS-1) is a rare genetic disease linked to mutations in the autoimmune regulator gene, affecting mainly endocrine organs but also showing autoantibody reactivity to brain structures.
  • In a study of 44 Finnish patients with APS-1, 23% were diagnosed with neurological disorders, with migraines, CNS infections, and epilepsy being the most common conditions.
  • Serum antineuronal antibodies were found in 42% of 24 tested patients, with GAD65 antibodies being prevalent, indicating a possible connection between APS-1 and neurological issues that require more research.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!